Skip to main content
Log in

Health-related quality of life of HIV-infected women: evidence for the reliability, validity and responsiveness of the Medical Outcomes Study Short-Form 20

  • Research Papers
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

The purpose of this study was to assess the reliability, validity and responsiveness of a health-related quality of life (HRQOL) instrument, the Medical Outcomes Short-Form 20-ltem General Health Survey (MOS SF-20), in a sample of women with the human immunodeficiency virus (HIV). Longitudinal data were collected on 202 HIV-infected women without AIDS who were receiving care at Kings County Hospital or SUNY Health Sciences Center, Brooklyn, New York. Internal consistency results showed acceptable reliability for the four multi-item MOS scales (role function, physical function, general health perceptions and mental health). Symptomatic patients and patients with lower Karnofsky Performance Status (KPS) ratings reported lower HRQOL than those who were asymptomatic or who had higher KPS scores. Patients who were older, unemployed or who had a history of injection drug use (IDU) also reported lower HRQOL. than those who were younger, employed or who had no drug use history. Adjusted mean scores on the MOS role and physical functioning scales proved sensitive to differences in clinical status over time. The MOS SF-20 is a reliable and valid instrument of HRQOL for women with HIV infection. Its sensitivity to differences in clinical status over time suggest that it may be useful as an HRQOL indicator for HIV/AIDS clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Centers for Disease Control. Estimates of HIV prevalence and projected AIDS cases: Summary of a workshop, October 31-November 1, 1989. Morbidity and Mortality Weekly Report Atlanta: Centers for Disease Control. 1990: February.

    Google Scholar 

  2. Melnick S.L., Sherer R, Louis T.A. et al. Survival and disease progression according to gender of patients with HIV infection. Amer Med Assoc 1994; 272(24): 1915–1921.

    Google Scholar 

  3. Centers for Disease Control. HIV/AIDS surveillance report (through November, 1994). Atlanta: Centers for Disease Control. 1994: December.

    Google Scholar 

  4. Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991; 253: 37–42.

    Google Scholar 

  5. New York City Department of Health AIDS surveillance update: Third quarter, 1995.

  6. Minkoff H, DeHovitz JA. Care of women infected with human immunodeficiency virus. J Amer Med Assoc 1991; 266: 2253–2258.

    Google Scholar 

  7. Carpenter CCJ, Mayer KG, Fisher A, et al. (1989) Natural history of acquired immunodeficiency syndrome in women in Rhode Island. Amer J Med 1989; 86: 771–776.

    Google Scholar 

  8. Carpenter CCJ, Mayor KH, Stein MD, et al. Human immuodeficiency virus infection in North American women: experience with 200 cases and a review of the literature. Med 1991; 70: 307–325.

    Google Scholar 

  9. Friedland GH, Saltsman B, Vileno J, Freeman K, Schrager LK, Klein RS. Survival differences in patients with AIDS. J Acq Imm Def Sym 1991; 4: 144–153.

    Google Scholar 

  10. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency infection. Ann Int Med 1992; 116: 129–137.

    Google Scholar 

  11. Kaplan RM, Anderson JP, Wu AW, Matthews WC, Kozin F, Orenstein D. The Quality of Well-Being Scale: Applications in AIDS, cystic fibrosis, and arthritis. Med Care 1989; 27(3): S27-S43.

    Google Scholar 

  12. Wu AW, Matthews WC, Brysk LT, et al. (1990) Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J Acq Imm Def Sym 1990; 3: 683–6xx.

    Google Scholar 

  13. Wu AW, Rubin HR, Matthews WC, et al., A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Med Care 1991; 29(8): 786–798.

    Google Scholar 

  14. Lubeck D, Fries J. Quality of life among persons with HIV infection. In: Proceedings of VIII International Conference on AIDS. Amsterdam: #PoB3568. 1992.

  15. Ganz PA, Coscarelli Schag CA, Kahn B, Petersen L, Hirji K. Describing the health-related quality of life impact of HIV infection: Findings from a study using the HIV Overview of Problems-Evaluation System (HOPES). Qual Life Res 1993; 2: 109–119.

    Google Scholar 

  16. Revicki D, Wu AW, Murray MI. Change in clinical status, health status and health utility outcomes in HIV-infected patients. Med Care 1995; 33(4): AS173-AS182.

    Google Scholar 

  17. Burgess A, Catalan J, Deyer M, et al. The reliability and validity of two HIV-specific health-related quality of life measures. AIDS 1993; 7: 1001–1009.

    Google Scholar 

  18. Lubeck DF, Fries JP. Health status among persons infected with human immunodeficiency virus: A community-based study. Med Care 1993; 31: 269–276.

    Google Scholar 

  19. Hays RD, Shapiro MF. An overview of generic health related quality of life measures for HIV research. Qual Life Res 1992; 1: 91–101.

    Google Scholar 

  20. Cunningham WE, Bozzette SA, Hays RD, Kanouse DE, Shapiro MF. Comparison of health-related quality of life in a clinical trial and nonclinicial trial human immunodeficiency virus-infected cohort. Med Care 1995; 33: AS15-AS25.

    Google Scholar 

  21. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988; 26: 724–735.

    Google Scholar 

  22. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report 1987; 36: 3S-15S.

    Google Scholar 

  23. Schag CC, Heinrich RL, Ganz PA. Karnofsky Performance Status Revisited: Reliability, Validity and Guidelines. J Clinical Oncology 1984; 2(3): 187–193.

    Google Scholar 

  24. National Institute of Allergy and Infectious Disease: AIDS Clinical Trials Group, Protocol ACTG, 241. pg 18.

  25. Fishl MA, Richman DD, Greico MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New Eng J Med 1987; 317: 185–191.

    Google Scholar 

  26. Connolly KJ, Allan JD, Fitch H, et al. Phase I study of 2′, 3′ dideoxysine administered orally twice daily to patients with AIDS or AIDS-related complex and hemotologic intolerance to zidovudine. Amer J Med 1991; 91: 471–478.

    Google Scholar 

  27. Fischl MA, Olson RM, Follansbee SE et al. Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy. Anh Int Med 1993; 118: 762–769.

    Google Scholar 

  28. Little J. AIDS home health care attendant and hospice care pilot project. Los Angeles: California Department of Health Services, 1988: 53.

    Google Scholar 

  29. Wu AW, Rubin HR. Measuring health status and quality of life in HIV and AIDS. Psych Health 1992; 6: 251–264.

    Google Scholar 

  30. Schag CC, Heinrich RL, Ganz PA. Karnofsky Performance Status revisited: reliability, validity and guidelines. J Clin Oncol 1984; 2: 187–193.

    Google Scholar 

  31. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status: An examination of its reliability and validity in a research setting. Cancer 1984; 53: 2202–2207.

    Google Scholar 

  32. Grieco A, Long CJ. Investigation of the Karnofsky Performance Status as a measure of quality of life. Health Psych 1984; 3: 129–142.

    Google Scholar 

  33. McDowell I, Newell C, eds. Measuring health: A guide to rating scales and questionnaires, New York: Oxford University Press, 1987.

    Google Scholar 

  34. Stewart A., Hays RD, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26: 786–798.

    Google Scholar 

  35. Stewart AL, Hays RD, Ware JE. Methods of validating MOS health measures. In. Measuring functioning and well-being: The Medical Outcomes Study approach. Durham: Duke University Press. 1992.

    Google Scholar 

  36. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27(3): S178-S189.

    Google Scholar 

  37. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297–334.

    Google Scholar 

  38. Verbrugge L. Gender and health: An update on hypotheses and evidence. J Health Soc Beh 1985; 26: 156–182.

    Google Scholar 

  39. Verbrugge L. The twain meet: Empirical explanations of sex differences in health and mortality. J Health Soc Beh 1989; 30: 282–304.

    Google Scholar 

  40. Stowe A, Ross MW, Wodak A, Thomas GV, Larson SA. Significant relationships and social supports of injecting drug users and their implications for HIV/AIDS services. AIDS Care 1993; 5(1): 23–33.

    Google Scholar 

  41. Stein M, Piette J, Mor V, et al. Differences in access to azidothymidine (AZT) among symptomatic HIV-infected persons. J Gen Int Med 1991; 6: 35–40.

    Google Scholar 

  42. Roche A, Guray C, Saunders J. General practitioners' experiences of patients with drug and alcohol problems. Brit J Addic 1991; 86: 263–275.

    Google Scholar 

  43. Wu AW, Rubin HR, Matthews WC, et al. Functional status and well-being in a placebo-controlled trial of zidovudine in early AIDS-related complex. J Acq Imm Def Sym 1993; 6: 452–460.

    Google Scholar 

  44. Breitbart W, Passik S, Bronough T, ea al. Pain in the ambulatory AIDS patient: prevalence and psychosocial correlates (abstract). 38th Annual Meeting, Academy of Psychosomatic Medicine, October 17–20, Atlanta, Georgia. 1991.

  45. Breitbart W, Passik S, Rosenfeld B, McDonald M, Thaler H, Portenoy R. Undertreatment of pain in AIDS (abstract). 13th Annual Meeting, American Pain Society, November 10–13, Miami, Florida. 1994: 17–20.

  46. Smith MY, Rapkin BD. Social support and barriers to family involvement in caregiving for persons with AIDS: Implications for patient education. Patient Edu Coun (in press).

  47. Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993; 2: 441–449.

    Google Scholar 

  48. MacKenzie CR, Charlson ME, DiGoia D, et al. Can the Sickness Impact Profile measure change? An example of scase assessment. J Chronic Disease 1986; 39: 429–438.

    Google Scholar 

  49. Chambers LW, Haight M, Norman G, et al. Sensitivity to change and the effect of mode of administration on health status measurement. Med Care 1987; 25: 470–480.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, M.Y., Feldman, J., Kelly, P. et al. Health-related quality of life of HIV-infected women: evidence for the reliability, validity and responsiveness of the Medical Outcomes Study Short-Form 20. Qual Life Res 5, 47–55 (1996). https://doi.org/10.1007/BF00435968

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00435968

Key words

Navigation